1. Saklayen, MG . The global epidemic of the metabolic syndrome. Curr Hypertens Rep 2018;20:1–8.
Google Scholar | Crossref | Medline2. Etchegoyen, M, Nobile, MH, Baez, F, et al. Metabolic syndrome and neuroprotection. Front Neurosci 2018;12:1–14.
Google Scholar | Crossref | Medline3. Bassi, R, Trevisani, A, Tezza, S, et al. Regenerative therapies for diabetic microangiopathy. Exp Diabetes Res 2012;2012:1–11.
Google Scholar | Crossref4. Ogurtsova, K, da Rocha Fernandes, JD, Huang, Y, et al. IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 2017;128:40–50.
Google Scholar | Crossref | Medline5. Kelly, T, Yang, W, Chen, C-S, et al. Global burden of obesity in 2005 and projections to 2030. Int J Obes 2008;32:1431–1437.
Google Scholar | Crossref | Medline | ISI6. Schaper, NC, Van Netten, JJ, Apelqvist, J, et al. Prevention and management of foot problems in diabetes: a summary guidance for daily practice 2015, based on the IWGDF guidance documents. Diabetes Metab Res Rev 2016;32:7–15.
Google Scholar | Crossref | Medline7. Apelqvist, J, Bakker, K, van Houtum, WH, et al. Practical guidelines on the management and prevention of the diabetic foot. Diabetes Metab Res Rev 2008;24:S181–S187.
Google Scholar | Crossref | Medline | ISI8. Boulton, AJM . Management of diabetic peripheral neuropathy. Clin Diabetes 2005;23:9–15.
Google Scholar | Crossref9. Stino, AM, Smith, AG. Peripheral neuropathy in prediabetes and the metabolic syndrome. J Diabetes Investig 2017;8:646–655.
Google Scholar | Crossref | Medline10. Rao, H, Gaur, N, Tipre, D. Assessment of diabetic neuropathy with emission tomography and magnetic resonance spectroscopy. Nucl Med Commun 2017;38:275–284.
Google Scholar | Crossref | Medline11. Dyck, PJ, Davies, JL, Wilson, DM, et al. Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester diabetic neuropathy study cohort. Diabetes Care 1999; 22: 1479–1486.
Google Scholar | Crossref | Medline | ISI12. Inceu, GV, Veresiu, IA. Measurement of current perception thresholds using the neurometer® – applicability in diabetic neuropathy. Med Pharm Reports 2015;88:449–452.
Google Scholar | Crossref13. Ziegler, D, Rathmann, W, Dickhaus, T, et al. Neuropathic pain in diabetes, prediabetes and normal glucose tolerance: the MONICA/KORA Augsburg surveys S2 and S3. Pain Med 2009;10:393–400.
Google Scholar | Crossref | Medline | ISI14. Müllner, E, Röhnisch, HE, von Brömssen, C, et al. Metabolomics analysis reveals altered metabolites in lean compared with obese adolescents and additional metabolic shifts associated with hyperinsulinaemia and insulin resistance in obese adolescents: a cross-sectional study. Metabolomics 2021;17:1–13.
Google Scholar | Crossref | Medline15. Malhotra, R, Chan, CS-Y, Nather, A. Osteomyelitis in the diabetic foot. Diabet Foot Ankle 2014;5:1–8.
Google Scholar | Crossref16. Kumar, K . A novel approach of 67-gallium-citrate three-phase bone scan to diagnose bone infection: a report of three cases. Indian J Nucl Med 2016;31:260–266.
Google Scholar | Crossref | Medline17. Devillers, A, Moisan, A, Hennion, F, et al. Contribution of technetium-99m hexamethylpropylene amine oxime labelled leucocyte scintigraphy to the diagnosis of diabetic foot infection. Eur J Nucl Med Mol Imaging 1998;25:132–138.
Google Scholar | Crossref18. Kampen, WU, Westphal, F, Van den Wyngaert, T, et al. SPECT/CT in postoperative foot and ankle pain. Semin Nucl Med 2018;48:454–468.
Google Scholar | Crossref | Medline19. Treglia, G, Sadeghi, R, Annunziata, S, et al. Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography for the diagnosis of osteomyelitis related to diabetic foot: a systematic review and a meta-analysis. Foot 2013;23:140–148.
Google Scholar | Crossref | Medline20. Bakker, K, Apelqvist, J, Lipsky, BA, et al. The 2015 IWGDF guidance documents on prevention and management of foot problems in diabetes: development of an evidence-based global consensus. Diabetes Metab Res Rev 2016;32:2–6.
Google Scholar | Crossref | Medline | ISI21. Fragoso Costa, P, Santos, A, Vidovič, B. EANM Brain Imaging, A Technologist’s Guide. Vienna: European Association of Nuclear Medicine (EANM), 2016:1–128.
Google Scholar22. Kapucu, ÖL, Nobili, F, Varrone, A, et al. EANM procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals, version 2. Eur J Nucl Med Mol Imaging 2009;36:2093–2102.
Google Scholar | Crossref | Medline | ISI23. Reba, HRC, Reba, ERC. Radiopharmaceuticals and brain pathology studied with PET and SPECT. Boca Raton, FL: CRC Press, 1990.
Google Scholar24. Ji, LL, Fu, R, Mitchell, EW. Glutathione and antioxidant enzymes in skeletal muscle: effects of fiber type and exercise intensity. J Appl Physiol 1992;73:1854–1859.
Google Scholar | Crossref | Medline25. Baldelli, S, Ciccarone, F, Limongi, D, et al. Glutathione and nitric oxide: key team players in use and disuse of skeletal muscle. Nutrients 2019;11:2318. DOI: 10.3390/nu11102318. PMID: 31575008, PMCID: PMC6836164.
Google Scholar | Crossref26. Képes, Z, Nagy, F, Budai, Á, et al. BMI and diabetes as independent predictors of brain hypoperfusion. Nucl Med Rev 2021;24:11–15.
Google Scholar | Crossref | Medline27. Inceu, GV, Veresiu, IA. Assessment of Peripheral Diabetic Neuropathy: New versus Conventional Methods. In: Vlad S, Ciupa R (eds). International Conference on Advancements of Medicine and Health Care through Technology, Springer, Cham, 5th – 7th June 2014, Springer: Cluj-Napoca, Romania, 2014:177–180. DOI: 10.1007/978-3-319-07653-9_36.
Google Scholar | Crossref28. Ferik, S, Güven, H, Ateş, MP, et al. Diabetic polyneuropathy, deep white matter lesions, and carotid atherosclerosis: is there any association? Neurol Sci 2018;39:103–110.
Google Scholar | Crossref | Medline29. Girach, A, Vignati, L. Diabetic microvascular complications—can the presence of one predict the development of another? J Diabetes Complications 2006;20:228–237.
Google Scholar | Crossref | Medline30. Ix, JH, Biggs, ML, Kizer, JR, et al. Association of body mass index with peripheral arterial disease in older adults: the cardiovascular health study. Am J Epidemiol 2011;174:1036–1043.
Google Scholar | Crossref | Medline | ISI31. Cade, WT . Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Phys Ther 2008;88:1322–1335.
Google Scholar | Crossref | Medline | ISI32. Werner, RA, Rischpler, C, Onthank, D, et al. Retention kinetics of the 18F-labeled sympathetic nerve PET tracer LMI1195: comparison with 11C-hydroxyephedrine and 123I-MIBG. J Nucl Med 2015;56:1429–1433.
Google Scholar | Crossref | Medline33. Goldstein, DS, Chang, PC, Eisenhofer, G, et al. Positron emission tomographic imaging of cardiac sympathetic innervation and function. Circulation 1990;81:1606–1621.
Google Scholar | Crossref | Medline | ISI34. Sen, CK . Glutathione: a key role in skeletal muscle metabolism. In: Reznick AZ, Packer L, Sen CK, Holloszy JO, Jackson MJ (eds). Oxid Stress Skelet Muscle. MCBU Molecular and Cell Biology Updates. Birkhäuser, Basel, 1998:127–139. Print ISBN: 978-3-0348-9844-7, Online ISBN: 978-3-0348-8958-2. DOI: 10.1007/978-3-0348-8958-2_8.
Google Scholar | Crossref35. Putz, Z, Tabak, AG, Toth, N, et al. Noninvasive evaluation of neural impairment in subjects with impaired glucose tolerance. Diabetes Care 2009;32:181–183.
Google Scholar | Crossref | Medline | ISI36. Schnurr, TM, Jakupović, H, Carrasquilla, GD, et al. Obesity, unfavourable lifestyle and genetic risk of type 2 diabetes: a case-cohort study. Diabetologia 2020;63:1324–1332.
Google Scholar | Crossref | Medline37. Hällsten, K, Yki-Järvinen, H, Peltoniemi, P, et al. Insulin- and exercise-stimulated skeletal muscle blood flow and glucose uptake in obese men. Obes Res 2003;11:257–265.
Google Scholar | Crossref | Medline